nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.085	0.12	CbGbCtD
Gemfibrozil—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0644	0.0908	CbGbCtD
Gemfibrozil—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0451	0.0635	CbGbCtD
Gemfibrozil—CYP2C8—Dapsone—systemic lupus erythematosus	0.0415	0.0585	CbGbCtD
Gemfibrozil—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0406	0.0572	CbGbCtD
Gemfibrozil—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.036	0.0507	CbGbCtD
Gemfibrozil—CYP2C19—Dapsone—systemic lupus erythematosus	0.0348	0.049	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0341	0.048	CbGbCtD
Gemfibrozil—CYP2C9—Dapsone—systemic lupus erythematosus	0.0289	0.0408	CbGbCtD
Gemfibrozil—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0289	0.0407	CbGbCtD
Gemfibrozil—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0273	0.0384	CbGbCtD
Gemfibrozil—CYP2C19—Prednisone—systemic lupus erythematosus	0.0241	0.034	CbGbCtD
Gemfibrozil—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0229	0.0322	CbGbCtD
Gemfibrozil—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0193	0.0271	CbGbCtD
Gemfibrozil—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.019	0.0268	CbGbCtD
Gemfibrozil—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.018	0.0253	CbGbCtD
Gemfibrozil—CYP3A4—Dapsone—systemic lupus erythematosus	0.0168	0.0237	CbGbCtD
Gemfibrozil—CYP2C9—cardial valve—systemic lupus erythematosus	0.0157	0.233	CbGeAlD
Gemfibrozil—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0151	0.0212	CbGbCtD
Gemfibrozil—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0146	0.0206	CbGbCtD
Gemfibrozil—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0146	0.0206	CbGbCtD
Gemfibrozil—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0125	0.0176	CbGbCtD
Gemfibrozil—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0125	0.0176	CbGbCtD
Gemfibrozil—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0124	0.0174	CbGbCtD
Gemfibrozil—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0117	0.0165	CbGbCtD
Gemfibrozil—CYP3A4—Prednisone—systemic lupus erythematosus	0.0117	0.0164	CbGbCtD
Gemfibrozil—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0111	0.0156	CbGbCtD
Gemfibrozil—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00728	0.0103	CbGbCtD
Gemfibrozil—PPARA—blood plasma—systemic lupus erythematosus	0.00548	0.0813	CbGeAlD
Gemfibrozil—CYP2C19—urine—systemic lupus erythematosus	0.00436	0.0647	CbGeAlD
Gemfibrozil—CYP1A2—urine—systemic lupus erythematosus	0.00356	0.0529	CbGeAlD
Gemfibrozil—SLCO1B1—blood plasma—systemic lupus erythematosus	0.0035	0.0519	CbGeAlD
Gemfibrozil—CYP2C9—urine—systemic lupus erythematosus	0.00338	0.0502	CbGeAlD
Gemfibrozil—PPARA—connective tissue—systemic lupus erythematosus	0.00292	0.0433	CbGeAlD
Gemfibrozil—PPARA—skin of body—systemic lupus erythematosus	0.00264	0.0391	CbGeAlD
Gemfibrozil—CYP3A4—urine—systemic lupus erythematosus	0.00258	0.0383	CbGeAlD
Gemfibrozil—PPARA—kidney—systemic lupus erythematosus	0.00249	0.0369	CbGeAlD
Gemfibrozil—CYP2C19—blood plasma—systemic lupus erythematosus	0.00228	0.0338	CbGeAlD
Gemfibrozil—PPARA—lymphoid tissue—systemic lupus erythematosus	0.00213	0.0317	CbGeAlD
Gemfibrozil—CYP2C8—blood plasma—systemic lupus erythematosus	0.00199	0.0295	CbGeAlD
Gemfibrozil—CYP1A2—blood plasma—systemic lupus erythematosus	0.00186	0.0276	CbGeAlD
Gemfibrozil—CYP2C9—blood plasma—systemic lupus erythematosus	0.00177	0.0262	CbGeAlD
Gemfibrozil—PPARA—lung—systemic lupus erythematosus	0.00176	0.0261	CbGeAlD
Gemfibrozil—PPARA—nervous system—systemic lupus erythematosus	0.00163	0.0242	CbGeAlD
Gemfibrozil—SLCO1B1—kidney—systemic lupus erythematosus	0.00158	0.0235	CbGeAlD
Gemfibrozil—PPARA—central nervous system—systemic lupus erythematosus	0.00157	0.0233	CbGeAlD
Gemfibrozil—CYP3A4—blood plasma—systemic lupus erythematosus	0.00135	0.02	CbGeAlD
Gemfibrozil—CYP2C8—kidney—systemic lupus erythematosus	0.000901	0.0134	CbGeAlD
Gemfibrozil—CYP1A2—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.000882	0.0315	CbGpPWpGaD
Gemfibrozil—PPARA—REV-ERBA represses gene expression—RXRA—systemic lupus erythematosus	0.000723	0.0258	CbGpPWpGaD
Gemfibrozil—PPARA—RORA activates circadian gene expression—RXRA—systemic lupus erythematosus	0.0007	0.025	CbGpPWpGaD
Gemfibrozil—PPARA—PPAR Alpha Pathway—RXRA—systemic lupus erythematosus	0.000679	0.0242	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—RXRA—systemic lupus erythematosus	0.000679	0.0242	CbGpPWpGaD
Gemfibrozil—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—RXRA—systemic lupus erythematosus	0.000622	0.0222	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000615	0.0219	CbGpPWpGaD
Gemfibrozil—CYP3A4—kidney—systemic lupus erythematosus	0.00061	0.00905	CbGeAlD
Gemfibrozil—CYP1A2—lung—systemic lupus erythematosus	0.000597	0.00886	CbGeAlD
Gemfibrozil—SLCO1B1—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000565	0.0201	CbGpPWpGaD
Gemfibrozil—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—systemic lupus erythematosus	0.000512	0.0182	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000501	0.0179	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000496	0.0177	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000487	0.0174	CbGpPWpGaD
Gemfibrozil—PPARA—Activation of gene expression by SREBF (SREBP)—RXRA—systemic lupus erythematosus	0.000481	0.0171	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000454	0.0162	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional activation of mitochondrial biogenesis—RXRA—systemic lupus erythematosus	0.000437	0.0156	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transport of organic anions—ALB—systemic lupus erythematosus	0.000433	0.0154	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—systemic lupus erythematosus	0.000428	0.0153	CbGpPWpGaD
Gemfibrozil—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NR3C1—systemic lupus erythematosus	0.000417	0.0149	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000408	0.0146	CbGpPWpGaD
Gemfibrozil—CYP3A4—nervous system—systemic lupus erythematosus	0.0004	0.00594	CbGeAlD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000396	0.0141	CbGpPWpGaD
Gemfibrozil—CYP3A4—central nervous system—systemic lupus erythematosus	0.000386	0.00572	CbGeAlD
Gemfibrozil—PPARA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—RXRA—systemic lupus erythematosus	0.000384	0.0137	CbGpPWpGaD
Gemfibrozil—PPARA—Mitochondrial biogenesis—RXRA—systemic lupus erythematosus	0.000378	0.0135	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian Clock—RXRA—systemic lupus erythematosus	0.000373	0.0133	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000358	0.0128	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000346	0.0123	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—systemic lupus erythematosus	0.000332	0.0118	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000323	0.0115	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000321	0.0114	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptors—PPARG—systemic lupus erythematosus	0.000316	0.0113	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian Clock—NR3C1—systemic lupus erythematosus	0.000304	0.0108	CbGpPWpGaD
Gemfibrozil—PPARA—REV-ERBA represses gene expression—EP300—systemic lupus erythematosus	0.000299	0.0107	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000295	0.0105	CbGpPWpGaD
Gemfibrozil—PPARA—RORA activates circadian gene expression—EP300—systemic lupus erythematosus	0.000289	0.0103	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—RXRA—systemic lupus erythematosus	0.000285	0.0102	CbGpPWpGaD
Gemfibrozil—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000254	0.00905	CbGpPWpGaD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.00025	0.00891	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	0.000244	0.00869	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000238	0.0085	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	0.000228	0.00812	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—GADD45A—systemic lupus erythematosus	0.000227	0.00808	CbGpPWpGaD
Gemfibrozil—PPARA—Orphan transporters—RXRA—systemic lupus erythematosus	0.000224	0.00798	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—ADIPOQ—systemic lupus erythematosus	0.000219	0.00779	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000215	0.00766	CbGpPWpGaD
Gemfibrozil—PPARA—PPARA activates gene expression—RXRA—systemic lupus erythematosus	0.000214	0.00763	CbGpPWpGaD
Gemfibrozil—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—systemic lupus erythematosus	0.000211	0.00754	CbGpPWpGaD
Gemfibrozil—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	0.000209	0.00747	CbGpPWpGaD
Gemfibrozil—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000196	0.00101	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—systemic lupus erythematosus	0.000196	0.00101	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000196	0.00101	CcSEcCtD
Gemfibrozil—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000196	0.00101	CcSEcCtD
Gemfibrozil—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000196	0.00101	CcSEcCtD
Gemfibrozil—Headache—Azathioprine—systemic lupus erythematosus	0.000195	0.001	CcSEcCtD
Gemfibrozil—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000195	0.001	CcSEcCtD
Gemfibrozil—Dizziness—Leflunomide—systemic lupus erythematosus	0.000195	0.001	CcSEcCtD
Gemfibrozil—Constipation—Cyclosporine—systemic lupus erythematosus	0.000194	0.000998	CcSEcCtD
Gemfibrozil—Pain—Cyclosporine—systemic lupus erythematosus	0.000194	0.000998	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—systemic lupus erythematosus	0.000194	0.000994	CcSEcCtD
Gemfibrozil—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000193	0.000992	CcSEcCtD
Gemfibrozil—Angioedema—Betamethasone—systemic lupus erythematosus	0.000193	0.000992	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000191	0.000983	CcSEcCtD
Gemfibrozil—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000191	0.000983	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.00019	0.000977	CcSEcCtD
Gemfibrozil—Oedema—Triamcinolone—systemic lupus erythematosus	0.00019	0.000977	CcSEcCtD
Gemfibrozil—Vertigo—Betamethasone—systemic lupus erythematosus	0.00019	0.000976	CcSEcCtD
Gemfibrozil—Vertigo—Dexamethasone—systemic lupus erythematosus	0.00019	0.000976	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.00019	0.000975	CcSEcCtD
Gemfibrozil—Syncope—Betamethasone—systemic lupus erythematosus	0.00019	0.000974	CcSEcCtD
Gemfibrozil—Syncope—Dexamethasone—systemic lupus erythematosus	0.00019	0.000974	CcSEcCtD
Gemfibrozil—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.00019	0.000974	CcSEcCtD
Gemfibrozil—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00019	0.000974	CcSEcCtD
Gemfibrozil—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000187	0.000962	CcSEcCtD
Gemfibrozil—Vomiting—Leflunomide—systemic lupus erythematosus	0.000187	0.000962	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—RXRA—systemic lupus erythematosus	0.000187	0.00668	CbGpPWpGaD
Gemfibrozil—Shock—Triamcinolone—systemic lupus erythematosus	0.000187	0.000961	CcSEcCtD
Gemfibrozil—Alopecia—Prednisone—systemic lupus erythematosus	0.000187	0.00096	CcSEcCtD
Gemfibrozil—Shock—Methylprednisolone—systemic lupus erythematosus	0.000187	0.000959	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000186	0.000957	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000186	0.000956	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000186	0.000954	CcSEcCtD
Gemfibrozil—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000186	0.000954	CcSEcCtD
Gemfibrozil—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000186	0.000954	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000186	0.000954	CcSEcCtD
Gemfibrozil—Rash—Leflunomide—systemic lupus erythematosus	0.000186	0.000954	CcSEcCtD
Gemfibrozil—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000186	0.000953	CcSEcCtD
Gemfibrozil—Mental disorder—Prednisone—systemic lupus erythematosus	0.000185	0.000952	CcSEcCtD
Gemfibrozil—Nausea—Azathioprine—systemic lupus erythematosus	0.000185	0.000951	CcSEcCtD
Gemfibrozil—Headache—Leflunomide—systemic lupus erythematosus	0.000185	0.000947	CcSEcCtD
Gemfibrozil—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000947	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000184	0.000945	CcSEcCtD
Gemfibrozil—Convulsion—Betamethasone—systemic lupus erythematosus	0.000183	0.000941	CcSEcCtD
Gemfibrozil—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000183	0.000941	CcSEcCtD
Gemfibrozil—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000183	0.000938	CcSEcCtD
Gemfibrozil—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000181	0.000931	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000181	0.000931	CcSEcCtD
Gemfibrozil—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000181	0.000927	CcSEcCtD
Gemfibrozil—Myalgia—Betamethasone—systemic lupus erythematosus	0.00018	0.000925	CcSEcCtD
Gemfibrozil—Myalgia—Dexamethasone—systemic lupus erythematosus	0.00018	0.000925	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—PPARG—systemic lupus erythematosus	0.00018	0.00641	CbGpPWpGaD
Gemfibrozil—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.00018	0.000923	CcSEcCtD
Gemfibrozil—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000913	CcSEcCtD
Gemfibrozil—Pain—Prednisolone—systemic lupus erythematosus	0.000177	0.000908	CcSEcCtD
Gemfibrozil—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000176	0.000905	CcSEcCtD
Gemfibrozil—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000175	0.0009	CcSEcCtD
Gemfibrozil—Nausea—Leflunomide—systemic lupus erythematosus	0.000175	0.000898	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000174	0.000896	CcSEcCtD
Gemfibrozil—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000174	0.000894	CcSEcCtD
Gemfibrozil—Vision blurred—Prednisone—systemic lupus erythematosus	0.000174	0.000891	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000173	0.00089	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000173	0.000888	CcSEcCtD
Gemfibrozil—Pain—Hydrocortisone—systemic lupus erythematosus	0.000173	0.000887	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000173	0.000886	CcSEcCtD
Gemfibrozil—Oedema—Betamethasone—systemic lupus erythematosus	0.000173	0.000886	CcSEcCtD
Gemfibrozil—Oedema—Dexamethasone—systemic lupus erythematosus	0.000173	0.000886	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000173	0.000886	CcSEcCtD
Gemfibrozil—PPARA—Organelle biogenesis and maintenance—RXRA—systemic lupus erythematosus	0.000172	0.00612	CbGpPWpGaD
Gemfibrozil—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000171	0.000877	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00017	0.000875	CcSEcCtD
Gemfibrozil—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00017	0.000875	CcSEcCtD
Gemfibrozil—Anaemia—Prednisone—systemic lupus erythematosus	0.00017	0.000874	CcSEcCtD
Gemfibrozil—Shock—Betamethasone—systemic lupus erythematosus	0.00017	0.000872	CcSEcCtD
Gemfibrozil—Shock—Dexamethasone—systemic lupus erythematosus	0.00017	0.000872	CcSEcCtD
Gemfibrozil—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000169	0.000869	CcSEcCtD
Gemfibrozil—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000169	0.000869	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000169	0.000868	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000169	0.000868	CcSEcCtD
Gemfibrozil—Angioedema—Prednisone—systemic lupus erythematosus	0.000168	0.000864	CcSEcCtD
Gemfibrozil—SLCO1B1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000168	0.00598	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000167	0.00086	CcSEcCtD
Gemfibrozil—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000167	0.000858	CcSEcCtD
Gemfibrozil—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000166	0.000855	CcSEcCtD
Gemfibrozil—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000166	0.00593	CbGpPWpGaD
Gemfibrozil—Vertigo—Prednisone—systemic lupus erythematosus	0.000165	0.00085	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000165	0.000848	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000165	0.000848	CcSEcCtD
Gemfibrozil—Syncope—Prednisone—systemic lupus erythematosus	0.000165	0.000848	CcSEcCtD
Gemfibrozil—Urticaria—Prednisolone—systemic lupus erythematosus	0.000164	0.000844	CcSEcCtD
Gemfibrozil—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000164	0.000842	CcSEcCtD
Gemfibrozil—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000164	0.00084	CcSEcCtD
Gemfibrozil—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000163	0.000837	CcSEcCtD
Gemfibrozil—Pain—Triamcinolone—systemic lupus erythematosus	0.000163	0.000835	CcSEcCtD
Gemfibrozil—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000162	0.000831	CcSEcCtD
Gemfibrozil—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000161	0.000826	CcSEcCtD
Gemfibrozil—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.00016	0.000824	CcSEcCtD
Gemfibrozil—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.00016	0.00572	CbGpPWpGaD
Gemfibrozil—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00016	0.00082	CcSEcCtD
Gemfibrozil—Convulsion—Prednisone—systemic lupus erythematosus	0.00016	0.000819	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000159	0.000818	CcSEcCtD
Gemfibrozil—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000159	0.000817	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000157	0.000807	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000157	0.000807	CcSEcCtD
Gemfibrozil—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000157	0.000806	CcSEcCtD
Gemfibrozil—Myalgia—Prednisone—systemic lupus erythematosus	0.000157	0.000805	CcSEcCtD
Gemfibrozil—Arthralgia—Prednisone—systemic lupus erythematosus	0.000157	0.000805	CcSEcCtD
Gemfibrozil—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000157	0.000805	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000156	0.000803	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—systemic lupus erythematosus	0.000156	0.000802	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000156	0.0008	CcSEcCtD
Gemfibrozil—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000156	0.000799	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000155	0.000797	CcSEcCtD
Gemfibrozil—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000155	0.000796	CcSEcCtD
Gemfibrozil—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000155	0.000796	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000155	0.000795	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	0.000154	0.0055	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian Clock—EP300—systemic lupus erythematosus	0.000154	0.00549	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—NR3C1—systemic lupus erythematosus	0.000153	0.00544	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000152	0.00078	CcSEcCtD
Gemfibrozil—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000152	0.00078	CcSEcCtD
Gemfibrozil—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000152	0.00541	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000152	0.000779	CcSEcCtD
Gemfibrozil—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000152	0.00541	CbGpPWpGaD
Gemfibrozil—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000151	0.000776	CcSEcCtD
Gemfibrozil—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000151	0.000774	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000151	0.000774	CcSEcCtD
Gemfibrozil—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00015	0.000772	CcSEcCtD
Gemfibrozil—Oedema—Prednisone—systemic lupus erythematosus	0.00015	0.000772	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.00015	0.000772	CcSEcCtD
Gemfibrozil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.00015	0.00536	CbGpPWpGaD
Gemfibrozil—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00015	0.00077	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000149	0.000765	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000149	0.000765	CcSEcCtD
Gemfibrozil—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000149	0.000764	CcSEcCtD
Gemfibrozil—Fatigue—Betamethasone—systemic lupus erythematosus	0.000149	0.000764	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—FAS—systemic lupus erythematosus	0.000148	0.00527	CbGpPWpGaD
Gemfibrozil—Shock—Prednisone—systemic lupus erythematosus	0.000148	0.000759	CcSEcCtD
Gemfibrozil—Pain—Betamethasone—systemic lupus erythematosus	0.000148	0.000758	CcSEcCtD
Gemfibrozil—Pain—Dexamethasone—systemic lupus erythematosus	0.000148	0.000758	CcSEcCtD
Gemfibrozil—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000147	0.000757	CcSEcCtD
Gemfibrozil—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000147	0.000753	CcSEcCtD
Gemfibrozil—Skin disorder—Prednisone—systemic lupus erythematosus	0.000146	0.00075	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000145	0.000745	CcSEcCtD
Gemfibrozil—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000145	0.000744	CcSEcCtD
Gemfibrozil—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000145	0.000742	CcSEcCtD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	0.000144	0.00515	CbGpPWpGaD
Gemfibrozil—Rash—Cyclosporine—systemic lupus erythematosus	0.000143	0.000736	CcSEcCtD
Gemfibrozil—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000143	0.000735	CcSEcCtD
Gemfibrozil—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000143	0.000734	CcSEcCtD
Gemfibrozil—Headache—Cyclosporine—systemic lupus erythematosus	0.000142	0.000731	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—systemic lupus erythematosus	0.000142	0.000731	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000142	0.00073	CcSEcCtD
Gemfibrozil—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000142	0.00073	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000141	0.000725	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000141	0.000725	CcSEcCtD
Gemfibrozil—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.000724	CcSEcCtD
Gemfibrozil—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.000718	CcSEcCtD
Gemfibrozil—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.000717	CcSEcCtD
Gemfibrozil—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000139	0.000713	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—systemic lupus erythematosus	0.000138	0.00071	CcSEcCtD
Gemfibrozil—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000138	0.00071	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000138	0.000707	CcSEcCtD
Gemfibrozil—Urticaria—Betamethasone—systemic lupus erythematosus	0.000137	0.000704	CcSEcCtD
Gemfibrozil—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000137	0.000704	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000137	0.000703	CcSEcCtD
Gemfibrozil—Dizziness—Prednisolone—systemic lupus erythematosus	0.000137	0.000702	CcSEcCtD
Gemfibrozil—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000136	0.000701	CcSEcCtD
Gemfibrozil—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000136	0.000701	CcSEcCtD
Gemfibrozil—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000136	0.000701	CcSEcCtD
Gemfibrozil—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000136	0.000699	CcSEcCtD
Gemfibrozil—PPARA—PPARA activates gene expression—PPARG—systemic lupus erythematosus	0.000135	0.00482	CbGpPWpGaD
Gemfibrozil—Nausea—Cyclosporine—systemic lupus erythematosus	0.000135	0.000693	CcSEcCtD
Gemfibrozil—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000135	0.000693	CcSEcCtD
Gemfibrozil—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000135	0.000691	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—systemic lupus erythematosus	0.000134	0.00069	CcSEcCtD
Gemfibrozil—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000134	0.00069	CcSEcCtD
Gemfibrozil—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000134	0.000686	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—systemic lupus erythematosus	0.000133	0.000685	CcSEcCtD
Gemfibrozil—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000132	0.000679	CcSEcCtD
Gemfibrozil—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	0.000132	0.00472	CbGpPWpGaD
Gemfibrozil—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.000676	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—systemic lupus erythematosus	0.000131	0.000673	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—systemic lupus erythematosus	0.000131	0.000673	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000131	0.000673	CcSEcCtD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000131	0.00467	CbGpPWpGaD
Gemfibrozil—Rash—Prednisolone—systemic lupus erythematosus	0.00013	0.00067	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00013	0.000669	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00013	0.000668	CcSEcCtD
Gemfibrozil—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00013	0.000667	CcSEcCtD
Gemfibrozil—Fatigue—Prednisone—systemic lupus erythematosus	0.00013	0.000665	CcSEcCtD
Gemfibrozil—Headache—Prednisolone—systemic lupus erythematosus	0.00013	0.000665	CcSEcCtD
Gemfibrozil—Constipation—Prednisone—systemic lupus erythematosus	0.000129	0.00066	CcSEcCtD
Gemfibrozil—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000128	0.00066	CcSEcCtD
Gemfibrozil—Rash—Hydrocortisone—systemic lupus erythematosus	0.000127	0.000654	CcSEcCtD
Gemfibrozil—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000127	0.000653	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—systemic lupus erythematosus	0.000127	0.00065	CcSEcCtD
Gemfibrozil—Headache—Hydrocortisone—systemic lupus erythematosus	0.000127	0.00065	CcSEcCtD
Gemfibrozil—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000126	0.000646	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000126	0.000645	CcSEcCtD
Gemfibrozil—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000644	CcSEcCtD
Gemfibrozil—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000124	0.000636	CcSEcCtD
Gemfibrozil—Asthenia—Betamethasone—systemic lupus erythematosus	0.000124	0.000636	CcSEcCtD
Gemfibrozil—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000124	0.000636	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000123	0.000633	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000123	0.000632	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000123	0.000631	CcSEcCtD
Gemfibrozil—Nausea—Prednisolone—systemic lupus erythematosus	0.000123	0.000631	CcSEcCtD
Gemfibrozil—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000122	0.000627	CcSEcCtD
Gemfibrozil—Pruritus—Betamethasone—systemic lupus erythematosus	0.000122	0.000627	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000122	0.000627	CcSEcCtD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000121	0.00432	CbGpPWpGaD
Gemfibrozil—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000121	0.000621	CcSEcCtD
Gemfibrozil—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00062	CcSEcCtD
Gemfibrozil—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000616	CcSEcCtD
Gemfibrozil—Rash—Triamcinolone—systemic lupus erythematosus	0.00012	0.000616	CcSEcCtD
Gemfibrozil—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.00012	0.000615	CcSEcCtD
Gemfibrozil—Rash—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000615	CcSEcCtD
Gemfibrozil—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000614	CcSEcCtD
Gemfibrozil—Urticaria—Prednisone—systemic lupus erythematosus	0.000119	0.000613	CcSEcCtD
Gemfibrozil—Headache—Triamcinolone—systemic lupus erythematosus	0.000119	0.000612	CcSEcCtD
Gemfibrozil—Headache—Methylprednisolone—systemic lupus erythematosus	0.000119	0.000611	CcSEcCtD
Gemfibrozil—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000119	0.00061	CcSEcCtD
Gemfibrozil—PPARA—Adipogenesis—PPARG—systemic lupus erythematosus	0.000118	0.00422	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000118	0.000606	CcSEcCtD
Gemfibrozil—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000118	0.000606	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	0.000118	0.00419	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000117	0.00417	CbGpPWpGaD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000114	0.000588	CcSEcCtD
Gemfibrozil—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000114	0.000586	CcSEcCtD
Gemfibrozil—Dizziness—Betamethasone—systemic lupus erythematosus	0.000114	0.000586	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000113	0.00403	CbGpPWpGaD
Gemfibrozil—Nausea—Triamcinolone—systemic lupus erythematosus	0.000113	0.00058	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000113	0.000579	CcSEcCtD
Gemfibrozil—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000113	0.000579	CcSEcCtD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000113	0.00402	CbGpPWpGaD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000112	0.00399	CbGpPWpGaD
Gemfibrozil—Somnolence—Methotrexate—systemic lupus erythematosus	0.000112	0.000573	CcSEcCtD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000111	0.00395	CbGpPWpGaD
Gemfibrozil—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000111	0.000568	CcSEcCtD
Gemfibrozil—Vomiting—Betamethasone—systemic lupus erythematosus	0.00011	0.000564	CcSEcCtD
Gemfibrozil—Vomiting—Dexamethasone—systemic lupus erythematosus	0.00011	0.000564	CcSEcCtD
Gemfibrozil—Rash—Dexamethasone—systemic lupus erythematosus	0.000109	0.000559	CcSEcCtD
Gemfibrozil—Rash—Betamethasone—systemic lupus erythematosus	0.000109	0.000559	CcSEcCtD
Gemfibrozil—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000109	0.000558	CcSEcCtD
Gemfibrozil—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000109	0.000558	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000108	0.000557	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—systemic lupus erythematosus	0.000108	0.000556	CcSEcCtD
Gemfibrozil—Headache—Betamethasone—systemic lupus erythematosus	0.000108	0.000555	CcSEcCtD
Gemfibrozil—Headache—Dexamethasone—systemic lupus erythematosus	0.000108	0.000555	CcSEcCtD
Gemfibrozil—Asthenia—Prednisone—systemic lupus erythematosus	0.000108	0.000554	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—systemic lupus erythematosus	0.000107	0.000552	CcSEcCtD
Gemfibrozil—Pruritus—Prednisone—systemic lupus erythematosus	0.000106	0.000546	CcSEcCtD
Gemfibrozil—PPARA—Circadian rythm related genes—FAS—systemic lupus erythematosus	0.000104	0.00372	CbGpPWpGaD
Gemfibrozil—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000104	0.000532	CcSEcCtD
Gemfibrozil—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000103	0.00367	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000103	0.000528	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000103	0.000527	CcSEcCtD
Gemfibrozil—Nausea—Betamethasone—systemic lupus erythematosus	0.000103	0.000526	CcSEcCtD
Gemfibrozil—Nausea—Dexamethasone—systemic lupus erythematosus	0.000103	0.000526	CcSEcCtD
Gemfibrozil—PPARA—Gene Expression—MTA2—systemic lupus erythematosus	0.000102	0.00365	CbGpPWpGaD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	0.000102	0.00365	CbGpPWpGaD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000101	0.00359	CbGpPWpGaD
Gemfibrozil—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.0001	0.00357	CbGpPWpGaD
Gemfibrozil—Urticaria—Methotrexate—systemic lupus erythematosus	9.98e-05	0.000512	CcSEcCtD
Gemfibrozil—Dizziness—Prednisone—systemic lupus erythematosus	9.94e-05	0.00051	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—systemic lupus erythematosus	9.93e-05	0.00051	CcSEcCtD
Gemfibrozil—Vomiting—Prednisone—systemic lupus erythematosus	9.56e-05	0.000491	CcSEcCtD
Gemfibrozil—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	9.55e-05	0.0034	CbGpPWpGaD
Gemfibrozil—Rash—Prednisone—systemic lupus erythematosus	9.48e-05	0.000487	CcSEcCtD
Gemfibrozil—Dermatitis—Prednisone—systemic lupus erythematosus	9.47e-05	0.000486	CcSEcCtD
Gemfibrozil—Headache—Prednisone—systemic lupus erythematosus	9.42e-05	0.000484	CcSEcCtD
Gemfibrozil—PPARA—Developmental Biology—LYN—systemic lupus erythematosus	9.3e-05	0.00332	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	9.17e-05	0.00327	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.14e-05	0.00326	CbGpPWpGaD
Gemfibrozil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	9.12e-05	0.00325	CbGpPWpGaD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	9.11e-05	0.00325	CbGpPWpGaD
Gemfibrozil—Asthenia—Methotrexate—systemic lupus erythematosus	9.01e-05	0.000463	CcSEcCtD
Gemfibrozil—Nausea—Prednisone—systemic lupus erythematosus	8.93e-05	0.000458	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—systemic lupus erythematosus	8.89e-05	0.000456	CcSEcCtD
Gemfibrozil—PPARA—PPARA activates gene expression—EP300—systemic lupus erythematosus	8.84e-05	0.00315	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	8.66e-05	0.00309	CbGpPWpGaD
Gemfibrozil—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	8.65e-05	0.00309	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	8.63e-05	0.00308	CbGpPWpGaD
Gemfibrozil—Diarrhoea—Methotrexate—systemic lupus erythematosus	8.59e-05	0.000441	CcSEcCtD
Gemfibrozil—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.54e-05	0.00305	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—PPARG—systemic lupus erythematosus	8.34e-05	0.00298	CbGpPWpGaD
Gemfibrozil—Dizziness—Methotrexate—systemic lupus erythematosus	8.31e-05	0.000427	CcSEcCtD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.16e-05	0.00291	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—CDKN1A—systemic lupus erythematosus	8.13e-05	0.0029	CbGpPWpGaD
Gemfibrozil—Vomiting—Methotrexate—systemic lupus erythematosus	7.99e-05	0.00041	CcSEcCtD
Gemfibrozil—PPARA—Developmental Biology—PTPRC—systemic lupus erythematosus	7.96e-05	0.00284	CbGpPWpGaD
Gemfibrozil—Rash—Methotrexate—systemic lupus erythematosus	7.92e-05	0.000407	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—systemic lupus erythematosus	7.91e-05	0.000406	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—systemic lupus erythematosus	7.87e-05	0.000404	CcSEcCtD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	7.84e-05	0.0028	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	7.8e-05	0.00278	CbGpPWpGaD
Gemfibrozil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	7.8e-05	0.00278	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	7.73e-05	0.00276	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	7.62e-05	0.00272	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—ADIPOQ—systemic lupus erythematosus	7.51e-05	0.00268	CbGpPWpGaD
Gemfibrozil—Nausea—Methotrexate—systemic lupus erythematosus	7.46e-05	0.000383	CcSEcCtD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	7.44e-05	0.00265	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	7.05e-05	0.00251	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.95e-05	0.00248	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—TNFSF13—systemic lupus erythematosus	6.91e-05	0.00246	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	6.84e-05	0.00244	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—TGFB1—systemic lupus erythematosus	6.72e-05	0.0024	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—SNRPB—systemic lupus erythematosus	6.69e-05	0.00239	CbGpPWpGaD
Gemfibrozil—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.48e-05	0.00231	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—RXRA—systemic lupus erythematosus	6.44e-05	0.0023	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.35e-05	0.00227	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—TNF—systemic lupus erythematosus	6.28e-05	0.00224	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—VDR—systemic lupus erythematosus	6.19e-05	0.00221	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.05e-05	0.00216	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	6.02e-05	0.00215	CbGpPWpGaD
Gemfibrozil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.02e-05	0.00215	CbGpPWpGaD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	5.96e-05	0.00213	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.94e-05	0.00212	CbGpPWpGaD
Gemfibrozil—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.78e-05	0.00206	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.75e-05	0.00205	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	5.57e-05	0.00199	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.46e-05	0.00195	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—EP300—systemic lupus erythematosus	5.46e-05	0.00195	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—JAK1—systemic lupus erythematosus	5.41e-05	0.00193	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—HIST2H2AC—systemic lupus erythematosus	5.37e-05	0.00192	CbGpPWpGaD
Gemfibrozil—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	5.27e-05	0.00188	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IL6—systemic lupus erythematosus	5.07e-05	0.00181	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	5.02e-05	0.00179	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.9e-05	0.00175	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	4.85e-05	0.00173	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	4.82e-05	0.00172	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	4.65e-05	0.00166	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.58e-05	0.00163	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NAT2—systemic lupus erythematosus	4.57e-05	0.00163	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	4.56e-05	0.00163	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	4.56e-05	0.00163	CbGpPWpGaD
Gemfibrozil—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	4.5e-05	0.00161	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	4.46e-05	0.00159	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	4.33e-05	0.00155	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	4.32e-05	0.00154	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	4.21e-05	0.0015	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—PPARG—systemic lupus erythematosus	4.06e-05	0.00145	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	4e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	4e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	3.95e-05	0.00141	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	3.79e-05	0.00135	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—JUNB—systemic lupus erythematosus	3.76e-05	0.00134	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.63e-05	0.00129	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—IL6—systemic lupus erythematosus	3.58e-05	0.00128	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TYK2—systemic lupus erythematosus	3.56e-05	0.00127	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	3.48e-05	0.00124	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.45e-05	0.00123	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	3.38e-05	0.0012	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—RXRA—systemic lupus erythematosus	3.29e-05	0.00117	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.26e-05	0.00116	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	3.25e-05	0.00116	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	3.25e-05	0.00116	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.24e-05	0.00116	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.1e-05	0.00111	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.08e-05	0.0011	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—VDR—systemic lupus erythematosus	2.98e-05	0.00106	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.85e-05	0.00102	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—systemic lupus erythematosus	2.8e-05	0.001	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—NR3C1—systemic lupus erythematosus	2.68e-05	0.000957	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EP300—systemic lupus erythematosus	2.66e-05	0.000948	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.6e-05	0.000929	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	2.58e-05	0.000919	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—RXRA—systemic lupus erythematosus	2.56e-05	0.000913	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—systemic lupus erythematosus	2.52e-05	0.000898	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.37e-05	0.000847	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TGFB1—systemic lupus erythematosus	2.31e-05	0.000824	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—systemic lupus erythematosus	2.16e-05	0.00077	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PPARG—systemic lupus erythematosus	2.08e-05	0.000741	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.05e-05	0.00073	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.86e-05	0.000665	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.84e-05	0.000657	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.75e-05	0.000624	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—IL6—systemic lupus erythematosus	1.74e-05	0.000621	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.66e-05	0.000593	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPARG—systemic lupus erythematosus	1.62e-05	0.000576	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.61e-05	0.000575	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.52e-05	0.000541	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.48e-05	0.000528	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ALB—systemic lupus erythematosus	1.45e-05	0.000518	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	1.44e-05	0.000515	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NOS3—systemic lupus erythematosus	1.39e-05	0.000496	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.34e-05	0.000478	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.32e-05	0.000471	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.3e-05	0.000462	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—systemic lupus erythematosus	1.27e-05	0.000453	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.2e-05	0.00043	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.18e-05	0.00042	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.06e-05	0.000377	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—EP300—systemic lupus erythematosus	1.06e-05	0.000377	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.05e-05	0.000375	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.03e-05	0.000367	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	9.58e-06	0.000342	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.44e-06	0.000337	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.26e-06	0.00033	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	9.12e-06	0.000325	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.61e-06	0.000307	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	8.3e-06	0.000296	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.26e-06	0.000295	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	8.2e-06	0.000292	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.18e-06	0.000292	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	7.95e-06	0.000283	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	7.84e-06	0.00028	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.7e-06	0.000275	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.53e-06	0.000269	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	7.41e-06	0.000264	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.36e-06	0.000262	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	7.17e-06	0.000256	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.87e-06	0.000245	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	6.75e-06	0.000241	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.44e-06	0.00023	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.27e-06	0.000223	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	5.97e-06	0.000213	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.77e-06	0.000206	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.35e-06	0.000191	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	5.24e-06	0.000187	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	4.71e-06	0.000168	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	4.68e-06	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	4.51e-06	0.000161	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.45e-06	0.000159	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	4.27e-06	0.000152	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	4.21e-06	0.00015	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	4.12e-06	0.000147	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	4.02e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.83e-06	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	3.68e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.67e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.64e-06	0.00013	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	3.43e-06	0.000122	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	3.36e-06	0.00012	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	3.28e-06	0.000117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	3.13e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	3.06e-06	0.000109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.87e-06	0.000102	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.81e-06	0.0001	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.79e-06	9.95e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.53e-06	9.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.42e-06	8.63e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.38e-06	8.51e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.21e-06	7.89e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.84e-06	6.56e-05	CbGpPWpGaD
